Fatal community-acquired bloodstream infection caused by Klebsiella variicola: A case report

Table 5 Results of bacterial culture and drug sensitivity

Specimen	Blood
Equipment	Phoenix100
Items	Bacterial culture + antimicrobial susceptibility
Results	Klebsiella pneumoniae
Antibiotics	MIC	Result interpretation	Cutoff
Cefotaxime		S	S ≤ 1; R ≥ 4
Cotrimoxazole	≤ 20	S	S ≤ 2/38; R ≥ 4/76
Tigecycline	≤ 0.5	S
Levofloxacin	≤ 0.12	S	S ≤ 0.5; R ≥ 2
Amikacin	≤ 2	S	S ≤ 16; R ≥ 64
Imipenem	≤ 0.25	S	S ≤ 1; R ≥ 4
Er ertapenem	≤ 0.12	S	S ≤ 0.5; R ≥ 2
Cefepime	≤ 0.12	S	S ≤ 2; R ≥ 16
Ce foperazone/sulbactam	≤ 8	S	S ≤ 16; R≥ 64
Ceftriaxone	≤ 0.25	S	S ≤ 1; R ≥ 4
Ceftazidime	≤ 0.12	S	S ≤ 4; R ≥ 16
Cefoxitin	≤ 4	S	S ≤ 8; R ≥ 32
Cefuroxime axetil	4	S
Cefuroxime	4	S	S ≤ 4; R ≥ 32
Piperacillin/tatabatam	≤ 4	S	S ≤ 16/4; R ≥ 128/4
Amoxicillin/clavulanate	≤ 2	S	S ≤ 8/4; R ≥ 32/16
ESBL	Neg	-

A blood sample was collected and examined following the standards of bacterial culture. The results of bacterial growth and antimicrobial susceptibility were acquired 24 h later.